Overview
Ai Proteins, a Boston-based biotech company utilizing artificial intelligence to develop de novo medicines, raised $41.5 million in Series A funding led by Mission BioCapital and Santรฉ Ventures, with participation from existing investors. The funds will support the expansion of operations and R&D efforts.
Products
Loading...
Recent Deals
Investors: Mission BioCapital, Santรฉ Ventures
Ai Proteins, a Boston-based biotech company utilizing artificial intelligence to develop de novo medicines, raised $41.5 million in Series A funding led by Mission BioCapital and Santรฉ Ventures, with participation from existing investors. The funds will support the expansion of operations and R&D efforts.